A Multi-Center Phase Ii Study Of Toripalimab With Chemotherapy In Patients With Egfr Mutant Advanced Nsclc Patients Resistant To Egfr Tkis: Efficacy And Biomarker Analysis.

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 10|浏览53
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要